In vitro efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 5, 2012, Pages 722-729

  Arslan, Mikail ^a   Gencer, Nahit ^a   Arslan, Oktay ^a   Guler, Ozen Ozensoy ^a  

^a BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Atropine sulphate; Dexamethasone; Furosemid; Gentamicin sulphate; Inhibition; Metamizole sodium; Oxytocin; Paraoxonase; Sulfadoxine trimethoprim; Toldimfos sodium

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ATROPINE; DEXAMETHASONE; DIPYRONE; FUROSEMIDE; GENTAMICIN; OXYTOCIN; SULFADOXINE PLUS TRIMETHOPRIM; TOLDIMFOS SODIUM; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CATTLE; DRUG EFFICACY; IC 50; IN VITRO STUDY; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CATTLE; ENZYME INHIBITORS; INHIBITORY CONCENTRATION 50; OXIDATION-REDUCTION; VETERINARY MEDICINE;

BOS; BOVINAE;

EID: 84866071802     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.611135     Document Type: Article

References (52)

1. Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong C. Characterisation of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 1991;30:10141-10149.
2. Aldridge WN. Serum esterases 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E 600) and its identity with the A-esterase of mammalian sera. Biochem J 1953;53:117-124.
3. Draganov D, La Du BN. Pharmacogenetics of paraoxonases: A brief review. Naunyn Schmiedebergs Arch Pharmacol 2004;369: 78-88. (Pubitemid 38161225)
4. Aviram M, Rosenblat M, Bisgaier C, et al. Paraoxonase inhibits highdensity lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101:1581-90. (Pubitemid 28198486)
5. Laplaud PM, Dantoine T, Chapman MJ. Paraoxonase as a risk marker for cardiovascular disease: Facts and hypotheses. Clin Chem Lab Med 1998;36:431-441. (Pubitemid 28419701)
6. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 1995;15: 1812-1818.
7. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem j 1973;134:707-716.
8. Nohl H, Gille L, Staniek K. The mystery of reactive oxygen species derived from cell respiration. Acta Biochim Pol 2004;51:223-229. (Pubitemid 38608820)
9. Videla LA. Energy metabolism, thyroid calorigenesis, and oxidative stress: Functional and cytotoxic consequences. Redox Report 2000;5:265-275.
10. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-1142. (Pubitemid 32606667)
11. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Investig 1993;91(6):2546-2551. (Pubitemid 23182507)
12. Walker CH, Mackness MI. "Aesterases and their role in regulating the toxicity of organophosphates. Arch Toxicol 1987;60:30-33. (Pubitemid 17081679)
13. Pellin MC, Moretto A, Lotti M, Vilanova E. Distribution and some biochemical properties of rat paraoxonase activity. Neurotoxicol Teratol 1990;12:611-614. (Pubitemid 20380101)
14. Costa LG, Li WF, Richter RJ, Shih DM, Lusis A, Furlong CE. The role of paraoxonase (PON1) in the detoxification of organophosphates and its human polymorphism. Chem Biol Interact 1999;119-120: 429-438. (Pubitemid 29278580)
15. Main AR. The role of A-esterase in the acute toxicity of paraoxon, TEPP, and parathion. Can j Biochem Physiol 1956;34:197-216.
16. Machin AF, Anderson PH, Quick MP, Waddell DF, Skibniewska KA and Howells LC. The metabolism of diazinon in the liver and blood of species of varying susceptibility to diazinon poisoning. Xenobiotica 1976;6:104.
17. Brealey CJ, Walker CH and Baldwin BC. A-esterase activities in relation to the differential toxicity of pirimiphos-methyl to birds and mammals. Pest Sci 1980;11:546-554. (Pubitemid 11162818)
18. Costa LG, Richter RJ, Murphy SD, Omenn GS, Motulsky AG and Furlong CE.(1987). Species differences in serum paraoxonase correlate with sensitivity to paraoxon toxicity. In: Costa LG, Galli CL and Murphy SD.Editors, Toxicology of Pesticides: Experimental Clinical and Regulatory Perspectives Heidelberg: Springer, 93-107.
19. Brodeur J, Dubois KP. Comparison of acute toxicity of anticholinesterase insecticides to weanling and adult male rats. Proc Soc Exp Biol Med 1963;114:509-511.
20. Benke GM, Murphy SD. The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats. Toxicol Appl Pharmacol 1975;31:254-269.
21. Virgo BB.(1984). Pesticides and the neonate. In: Kacew S and Reasor MJ.Editors, Toxicology and the Newborn. Amsterdam:Elsevier, 252-267.
22. Gençer N, Arslan O. Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals. j Chromatogr b Analyt Technol Biomed Life Sci 2009;877:134-140.
23. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-106.
24. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304-1316. (Pubitemid 39349234)
25. Butler WR. Nutritional interactions with reproductive performance in dairy cattle. Anim Reprod Sci 2000;60-61:446-457.
26. Lucy MC. Mechanisms linking nutrition and reproduction in postpartum cows. Reprod Suppl 2003;61:415-427.
27. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol 1998;31:329-336. (Pubitemid 28398854)
28. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 2003;8:1-12. (Pubitemid 36097533)
29. Ferré NJ, Camps E, Prats E, Vilella A, Figuera PL and Joven J. Serum paraoxonase activity: A new additional test for the improved evaluation of chronic liver damage. Clin Chem 2002;48:261-268. (Pubitemid 34107262)
30. Gibson GG & Skett P. Introduction to Drug Metabolism. 2nd Edn. Chapman & Hall, London, 1994.
31. Mlynarczuk J, Wrobel MH, Kotwica J. Effect of environmental pollutants on oxytocin synthesis and secretion from corpus luteum and on contractions of uterus from pregnant cows. Toxicol Appl Pharmacol 2010;247:243-249.
32. Weiss D, Dzidic A, Bruckmaier RM. Effect of stimulation intensity on oxytocin release before, during and after machine milking. j Dairy Res 2003;70:349-354. (Pubitemid 36953511)
33. Maciel SM, Chamberlain CS, Wettemann RP, Spicer LJ. Dexamethasone influences endocrine and ovarian function in dairy cattle. j Dairy Sci 2001;84:1998-2009. (Pubitemid 33616465)
34. Short CE. (1987). Anticholinergics. In: Short CE, ed. Veterinary Anesthesia Baltimore: Williams & Wilkins, 8-15.
35. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV and Lenz DE. Protection of butyrylcholinesterase against organophosphorus poisoning in non-human primates. J Pharmacol and Exp Therapeut Vol 1991;259:633-638.
36. Elsheikh HA, Osman IA, Ali BH. Comparative pharmacokinetics of ampicillin trihydrate, gentamicin sulphate and oxytetracycline hydrochloride in Nubian goats and desert sheep. j Vet Pharmacol Ther 1997;20:262-266. (Pubitemid 27316652)
37. Haddad NS, Ravis WR, Pedersoli WM, Carson RL Jr. Pharmacokinetics of single doses of gentamicin given by intravenous and intramuscular routes to lactating cows. Am j Vet Res 1986;47:808-813. (Pubitemid 16144199)
38. Available at: http://www.avma.org/onlnews/javma/aug04/040801b.asp. ccessed on 1 August 2004.39. Girton RA, Sundin DP, Rosenberg ME. lusterin protects renal tubular epithelial cells from gentamicin-mediated ytotoxicity. Am j Physiol Renal Physiol 2002;282:F703-F709. (Pubitemid 34654518)
39. White G, Piercy DW, Gibbs HA. Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo. Res Vet Sci 1981;31:27-31. (Pubitemid 11063260)
40. Gerald D, Mechor G, Kee J, Eugene D. Janzen Comparison of penicillin, oxytetracycline, and trimethoprim-sulfadoxine in the treatment of acute undifferentiated bovine respiratory disease. Can Vet J 1988;29:438-443.
41. Rehm WF, White G. A field trial with trimethoprim and sulfadoxine in bacterial diseases of cattle and pigs. Vet Rec 1970;87:39-42.
42. Timmerman RJ, Springman FR, Thoms RK. Evaluation of furosemide, a new diuretic agent. Curr Therapeut Res 1964;6:88-94.
43. Rais-Bahrami K, Majd M, Veszelovszky E, Short B. Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol 2004;21:329-32. (Pubitemid 39108813)
44. Anthony Wong in WHO. Pharmaceuticals Newsletter 2002; p15.
45. Available at: www.emea.europa.eu/pdfs/vet/mrls/071799en.pdf. Accessed December 1999
46. Ekinci D, Sentürk M, Beydemir S, Küfrevioǧlu O.I, Supuran CT An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides. Chem Biol Drug Des 2010;76:552-55.
47. Alici HA, Ekinci D, Beydemir S Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo. Clin Biochem 2008;41:1384-1390.
48. Ekinci D, Beydemir S. Evaluation of the impacts of antibiotic drugs on PON 1; A major bioscavenger against cardiovascular diseases. European J Pharmacol 2009;617:84-89.
49. Biggadike K, Angell RM, Burgess CM, Farrell RM, Hancock AP, Harker AJ, Irving WR, Ioannou C, Procopiou PA, Shaw RE, Solanke YE, Singh OM, Snowden MA, Stubbs RJ, Walton S, Weston HE. Selective plasma hydrolysis of glucocorticoid gammalactones and cyclic carbonates by the enzyme paraoxonase: An ideal plasma inactivation mechanism. J Med Chem 2000; 43:19-21. (Pubitemid 30055759)
50. Turk R, Juretic D, Geres D, Turk N, Rekic B, Simeon-Rudolf V and Svetina A. Serum paraoxonase activity and lipid parameters in the early postpartum period of dairy cows. Res Vet Sci 2004;76:57-61. (Pubitemid 38035532)
51. Beydemir Ş, Ekinci D and Ates O. In Vitro effects of dexamethasone on human serum paraoxonase-i (pon1) activity. hacettepe. J Biol & Chem 2009;37:197-205.
52. Sinan S, Kockar F, Gençer N, Yildirim H and Arslan O. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo. Biol Pharm Bull 2006; 29:1559-1563 (Pubitemid 44166351)